Safety and Tolerability of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy (IgAN)

Clinical trial NCT03945318 · COMPLETED

Trial details

NCT number: NCT03945318
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

IgA Nephropathy

Start date: 2019-04-08
Primary completion: 2026-06-10
Enrollment: 103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.